Tumefaction heterogeneity since the difficulty to own anti-HER2 treatment in the gastroesophageal cancer tumors
Tumefaction heterogeneity since the difficulty to own anti-HER2 treatment in the gastroesophageal cancer tumors As reported at 2018 ASCO annual …